Mirae Asset Global Etfs Holdings Ltd. Prothena Corp Public LTD CO Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 24,804 shares of PRTA stock, worth $448,456. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,804Holding current value
$448,456% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
180Shares Held
42.7MCall Options Held
77.7KPut Options Held
92.7K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$209 Million8.45% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.24MShares$76.6 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$69.7 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.64MShares$65.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.93MShares$34.9 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $848M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...